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GLOSSARY 
Adjuvant 
Alio 
Alloreactivity 
Alloantigen 
Alloantisera 
Allogeneic 
Alloimmunization 
Cellular immunity 
Chorioallantoic 
Membrane test 
(CAM test) 
Congenic 
GAT 
Graft-versus-host 
(GVH) reaction 
Major 
Histocompatibility 
Complex (MHC) 
An agent that enhances the immune response. 
A prefix used to indicate genetic nonidentity 
among members of the same species. 
Rejection of cellular allografts frcm genetically 
nonidentical members of the same species. 
A molecule that is antigenic when introduced into 
another member of the same species. 
Antisera which react specifically with antigenic 
determinants of members of the same species. 
Genetically nonidentical with respect to other 
members of the ^ecies. 
Immunizations with transplantation antigens within 
a species. 
Immune response involving effector T cells and not 
dependent on antibody production. 
Lymphocytes are deposited on the chorioallantoic 
membrane of the developing embryo and produce pocks 
in response to transplantation alloantigens. 
Genetic identity with respect to all loci except 
for a series of closely linked loci or a single 
locus. 
A polypeptide synthesized from alanine, tyrosine 
and glutamic acid residues and used as an antigen 
in studies of immune responsiveness. 
Response of grafted lymphocytes against the 
transplantation alloantigens of the host. 
A group of closely linked loci exerting a major 
effect on transplantation immunity. It is divisible 
into various regions on the basis of crossover 
analysis. Species designations include: Rat, Ag-B; 
Chicken, B; Mouse, H-2; Man, HL-A. 
V 
Mixed Lymphocyte 
Reaction (MLR) 
Mixed culture of lymphocytes from two donors and 
resulting in cellular proliferation if nonidentical 
at the MHC. 
Recoinbinant 
haplotype 
Restriction 
Serologically 
Defined (SD) 
The result of a crossover within the MHC in a 
heterozygous individual. 
Ability of a lymphocyte to recognize antigen only 
when presented by cells bearing autologous cell 
surface alloantigens. 
Blood cell antigens defined by the use of specific 
antisera. 
Splenomegaly 
Transplantation 
immunity 
Xeno 
Xenogeneic 
Enlargement of the spleen produced in embryonic 
poultry by intravenous injections of lymphocytes. 
The ability to reject cellular allografts. 
Prefix meaning between species. 
Refers to a species difference with respect to 
genetics. 
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INTRODUCTION 
The major histocompatibility complex (MHC) consists of a series of 
closely linked genes, first recognized because of their major influence 
on tissue graft rejection. During the past decade, the major emphasis 
of immunogenetic research has been on the MHC in all species studied. 
All mammals, and perhaps all vertebrates, possess an MHC. Although graft 
rejection is probably only incidental to its true function, the MHC is a 
formidable barrier to successful transplantation of tissues. The MHC, 
designated HLA in man, also is associated with certain diseases. Favor­
able MHC genes confer resistance to specific diseases and unfavorable MHC 
genes are associated with susceptibility. Studies of the MHC promise to 
provide new technologies which should help overcome barriers to trans­
plantation and improve the health and well-being of man as well as 
economically important species of animals. 
The natural functions of the MHC have been, until just a few years 
ago, only speculative. Early investigations, carried out both vivo 
and vitro in laboratory ^ecies, especially in the mouse, were unable 
to reveal its natural ^  vivo functions. Plausible theories have now 
been constructed which are amenable to valid experimental testing. Seem­
ingly, an important physiological function of the MHC is to provide for 
antigen recognition. That is, molecular structures of invading pathogens 
(antigens) become associated with molecular products coded by the MHC in 
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the initial physiological processes of the immune response. Only after 
the host and pathogen molecules are associated are they recognized as 
foreign. 
The rapid progress in inmunogenetics research should ultimately lead 
to the biochemical characterization of molecular products coded by the 
MHC and, therefore, provide a more complete understanding of their in 
vivo functions. The identification of genes linked to the murine and to 
the human MHC is now close at hand: workers are presently sequencing DNA 
fragments taken from mice and humans. Such information should help to 
develop a clearer picture of the function of the IfflC as related to its 
structure. Ultimately, the correction of genetic defects in humans may 
be possible when the defective gene is identified and its dysfunction is 
determined. 
As information on the human HLA system accumulates, catalogues of 
the immunological properties of the different HLA types are being con­
structed. Already, more than 50 diseases are known to be associated with 
the HLA. Refinements in typing techniques should make it possible to 
determine an individual's exact sequence of HLA alleles. With knowledge 
of the disease resistances and susceptibilities and autoimmunities con­
ferred by these alleles, it should be possible to tailor a very precise 
program of preventative medicine for the individual. 
Research in avian immunogenetics may have important implications for 
human medicine. From the point of view of evolutionary origin, the chicken 
is a more ancient species than man and, therefore, relationships between 
structure and function in this species may be more easily elucidated. 
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Information obtained from the study of the chicken MHC, or B coup lex, 
should complement that already known of the mammalian MHC. Models for 
the study of viral oncogenesis in chickens may reveal details necessary 
for a better understanding of oncogenic processes in humans. Moreover, 
studies of transplantation barriers in chickens may give clues which will 
help overcome barriers to organ transplantation in man. 
Knowledge of the physiological functions of the molecules coded by 
the may also have a major impact on the technology bearing on the 
health and well-being of the chicken. Avian immunogeneticists have long 
suspected a direct relationship between the B complex and disease. A B 
21 
complex type, designated B , has been identified as highly resistant to 
the virus induced lymphomas of Marek's disease when compared with a number 
of other commonly occurring haplotypes. This disease occurs naturally 
in commercial populations of chickens. More recently, a relationship be­
tween B complex types and regression of Rous sarcoma virus induced tumors 
has been established. 
Details of the genetic structure of the B complex are only now 
emerging. MHC recombinants are useful because they provide new MHC types 
which differ in small but important ways from the original types. They 
make it possible to determine the specific genes within the MHC which con­
fer resistance or susceptibility to disease. New and favorable genetic 
recombinants may well be the key to the improvement of both general and 
specific resistance of chickens to disease. 
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LITERATURE REVIEW 
The Major Histocompatibility Complex 
(MHC) in Mammals 
Structure of the mammalian MHC 
The murine H-2 system is the most extensively studied and best 
understood MHC. The H-2 complex was discovered by Peter Gorer in 1935 
using xenoantisera to recognize segregating blood group antigens (Gorer, 
1937). George Snell recognized the importance of histocompatibility 
phenomena in immunogenetics; he developed congenic lines that serve as a 
powerful tool in H-2 research (Snell, 1948, 1981). The subsequent pro­
duction of recombinant haplotypes made it possible to analyze the complex 
genetic structure of the H-2 complex (Amos et al., 1955; Allen, 1955). 
Details of the genetic structure of the H-2 complex have emerged 
gradually. At least 10 loci in the complex are distributed linearly on 
chromosome 17; K, [a^, A^, Eg], J, E^, [SS, Sip], [D, L]. The order of 
the loci enclosed in brackets is not known (Klein et al., 1981). 
The classical histocompatibility antigens, genetically coded by genes 
at the K, D and L loci, are designated Class I. They are of major impor­
tance in the control of allograft rejection. A and E antigens, coded by 
genes of the I region, are designated Class II. The A molecules are 
dimers of A^ and Ag polypeptides, and the E molecules are dimers of E^ and 
Eg polypeptides. Evidence indicates that immune response genes code for 
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the A and E antigens (Benacerraf, 1981). SS and Sip antigens of the S 
region, designated Class III, code for the C4 component of complement. 
The J antigens are expressed on suppressor T cells. 
The three classes of genes described above'are closely linked within 
the MHC of those species which have been examined sufficiently (Gfietze, 
1977). Details of the rat and guinea pig MHC, now emerging, suggest far 
less polymorphism of their MHC products compared with the mouse (Snell, 
1981). The three classes of antigens have also been found in the human 
HLA system. Biochemically, these antigens show close homology among all 
species studied. 
Function of the mammalian MHC 
An MHC has been found in all mammals which have been sufficiently 
investigated and perhaps they exist in all vertebrates (Snell, 1981). 
Although its function has been speculative for many years, plausible 
theories can now be tested experimentally (Benacerraf, 1981). The dis­
covery that immune response genes in the mouse were linked to the MHC 
provided the first experimental evidence for an MHC function (McDevitt 
and Chinitz, 1969). Subsequently, immune response genes have been found 
linked to the MHC of other mammals including man. 
Evidence indicates that helper T cells detect antigen (carrier) on 
the surface of "antigen-presenting cells" with morphology corresponding 
to macrophages. The antigen-presenting cells must bear autologous la 
antigens to stimulate helper T cell proliferation. In turn, the pro­
liferating T cells stimulate immunoglobulin production of hapten-specific 
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B cells with antigen bound to their immunoglobulin receptors. The B 
cells, too, must bear autologous la antigens. Antigen-presenting cells 
with autologous la antigens also stimulate T cells to proliferate and dif­
ferentiate into delayed hypersensitivity T cells. The necessity for 
autologous la antigens is called restriction (Benacerraf, 1981). 
Restriction is imposed on effector T cells by cell surface molecules 
coded by the K, D and L loci of the H-2 complex. Cytolytic T cells will 
lyse only those virus-infected target cells with K, D or L identity. Be­
cause T cell immune responses detect "self" by monitoring the cell surface, 
the function of the K, D or L molecules may be to indicate self. Modi­
fication of these molecules by viral antigens may be the signal of "non-
self" that results in cytolysis. Alloreactivity can be explained as the 
recognition of allotypic K, D or L as antigen modified self molecules 
(Benacerraf, 1981). 
In summary, it seems the immune response genes code for the la 
antigens and allow for the recognition of antigen on the surface of antigen-
presenting cells by helper T cells. la antigens expressed on the surface 
of B cells with antigen bound to their immunoglobulin receptors allows 
for stimulation of immunoglobulin production in B cells by helper T cells. 
Stated more sinçily, it seems that the primary purpose of the cell sur­
face alloantigens controlled by the MHC is to provide a context for anti­
gen recognition. 
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The Major Histocompatibility Complex 
(MHC) of the Chicken 
Variants controlled by the 
chicken MHC 
The chicken MHC (B complex) codes for homologues of the Class I and 
Class II antigens found in mammals. B-F antigens in the chicken, desig­
nated Class I, are recognized serologically by hemagglutination. They 
are glycoproteins with molecular weights of 40,000 to 43,000 daltons and 
are noncovalently associated with a 6-2 microglobulin-like molecule 
(Ziegler and Pink, 1975, 1976). B-L antigens, designated Class II, can 
also be detected with alloantisera. They are dimers of molecules with 
molecular weights of 32,000 and 27,000 daltons and correspond to the o and 
3 chains of the murine H-2 complex, respectively. They are distributed 
on both lymphocytes and macrophages (Kvist e^ , 1978; Brogren and 
Bisati, 1980). Recent evidence points to two populations of molecules in 
the chicken that are homologues of the mammalian Class II antigens (Crone 
et al., 1981). 
Class III antigens have not been recognized in the chicken but their 
existence is inferred because the B complex controls total complement 
activity (Chanh et al., 1976) . A cell surface antigen designated B-G 
with no known mammalian homologue has been found in the chicken; these 
are glycoproteins with a molecular weight of 43,000 daltons and are present 
on the surface of erythrocytes only. 
In addition to the control of alloantigens, the B complex controls 
histocompatibility. Skin transplantation, mixed lymphocyte reaction. 
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graft-versus-host splenomegaly and graft-versus-host chorioallantoic 
membrane pocks are all histocompatibility attributes controlled by the B 
complex. Total serum hemolytic complement levels are also controlled by 
the B complex (Chanh et al., 1976). 
An important function attributed to the B complex is control of the 
immune response. The haplotype^ identified with low immune response 
to GAT is characterized by low viability and low serum IgG levels (Pevzner 
et al.f 1975; Rees and Nordskog, 1981). Susceptibility to Rous sarcoma 
virus (Collins et al., 1977; Schierman et al., 1977) and Marek's disease 
resistance (Hanson et al., 1967; Pazderka et al., 1975) are controlled by 
the B complex. The development of spontaneous autoimmune thyroiditis is 
also controlled by the B complex (Bacon and Rose, 1979) . 
Genetic structure of the B complex 
Details of the linear order of genes in the B complex are meager. 
The first B recombinant, reported by Schierman and McBride (1969), pro­
vided evidence for multiple B conçlex loci coding for erythrocyte allo-
antigens. Hàla et al. (1976) discovered a single recombinant among 1,206 
chicks tested by hemagglutination. Briles and Briles (1977) detected a 
serological recombinant during routine blood typing and obtained two ad­
ditional recombinants from its progeny. Analysis of the recombinant 
obtained by Hàla et al. (1976) indicated that the crossover occurred be­
tween loci coding for the B-G antigens and B-F antigens. Loci of the B-F 
region control both the B-F and B-L antigens. The function of the B-G 
region is yet unknown (Vilhelmovà et al. , 1977; Ziegler and Pink, 1976). 
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Briles and Briles (1980) provided evidence for multiple B-G loci within 
the B complex. 
Pevzner efc (1978) reported a recombinant with a chromosome 
breakage between loci coding for serologically defined (SD) erythrocyte 
1 
alloantigens and the Ir-GAT locus. In the B parental haplotype, genes 
controlling B^ SD erythrocyte alloantigens were linked to Ir-GAT-Lo, a 
19 low responder allele. In the B parental haplotype, genes coding for 
19 
B SD erythrocyte alloantigens are linked to the Ir-GAT-Hi allele/ a 
high responder allele. In the recombinant B^ SD erythrocyte alloantigens 
are linked to the Ir-GAT-Hi allele. Thus, one recombinant haplotype is 
19 
a high responder to GAT. Another recombinant links B SD erythrocyte 
alloantigens and the Ir-GAT-Lo allele (Lee and Nordskog, 1981). The I 
region genes of the mouse were first identified as immune response genes; 
la antigens were discovered in an attempt to detect immune response gene 
products serologically (Shreffler and David, 1974). The question of 
whether the Ir-GAT locus controls homologues of the murine la antigens 
remains unresolved until the gene products of the Ir-GAT locus are se­
quenced. An alternative possibility is that the Ir-GAT locus codes for 
the T cell receptor for antigen (Benacerraf, 1981). 
Lee and Nordskog (1981) found that the B complex region coding for 
SD erythrocyte alloantigens and the region containing the Ir-GAT locus 
both contribute to the graft-versus-host splenomegaly reaction. The for­
mer region seemed to be of greater relative importance. If the graft-
versus-host reaction in the chicken is controlled by a homologue(s) of 
the murine la antigen, then at least one locus closely linked to the B-F 
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and B-G loci, and separate from the Ir-GAT locus, codes for an la 
homologue. Biochemical evidence, also, points to the presence of two loci 
coding for la-like molecules in the chicken (Crone et al., 1981). 
Schierman et al. (1977) provided evidence for a crossover between 
SD erythrocyte alloantigens and a locus controlling resistance to tumors 
induced by the Schmidt-Ruppin strain of Rous sarcoma virus. However, in­
complete penetrance of dominant genes for regression was not ruled out. 
Gebriel et al. (1979) showed that the Ir-GAT locus is a distinct entity 
but closely linked to a locus controlling resistance to tumors induced by 
the Bryan strain of Rous sarcoma virus. 
The genetic stiructure of the H-2 complex has been defined exclusively 
in terms of serological tests. Ideally, the chicken B complex should also 
be defined this way because genotypes cannot be determined definitively 
using tests which measure phenotypes quantitatively. The paucity of B 
complex loci with serologically detectable gene products has made mapping 
of the B complex difficult. The production of la alloantisera and mono­
clonal typing fluids specific for B complex alloantigens promises to speed 
the mapping of the B complex (Longenecker e^ al., 1979). 
Function of the B complex 
So far, little direct experimental evidence has been collected 
relating the B complex to a physiologically important function. In mam­
mals, MHC-coded cell surface alloantigens provide for antigen recognition 
(Benacerraf, 1981; Klein et al., 1981). Partial amino acid sequences have 
already shown homology of the B complex histocompatibility antigens 
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with murine (H-2) and human (HLA) histocompatibility antigens (Vitetta 
et al., 1977; Huser et al., 1978). Future work should lead to the bio­
chemical characterization of those molecules coded by the B complex. Be­
cause the B complex codes for Class I and Class II molecules, and because 
the B complex controls immune responsiveness, the primary physiological 
function of the cell surface molecules coded by the B complex should be 
closely homologous to that of the mammalian MHC. Future work using the 
chicken B complex, of a basic nature, should verify basic functions estab­
lished in other species. The fact that the chicken is more ancient on 
the evolutionary scale makes it a potentially valuable species for further 
experimentation and especially for studies on evolutionary homology. 
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MATERIALS AND METHODS 
Stocks 
Several lines of chickens, both inbred and outbred, are maintained 
at Iowa State University. Outbred line SI, originating from a cross of 
two commercial lines (Nordskog et al., 1973), segregates for three paren-
1 2 19 
tal B haplotypes; B -Ir-GAT-Lo, B -Ir-GAT-Intermediate, and B -Ir-GAT-Hi, 
B^-Ir-GAT-Lo homozygotes are low in both viability and humoral immune 
re^onse to certain antigens (Pevzner et al., 1975), Low viability and 
low humoral immune response have been linked to B^^ SD erythrocyte anti-
19 gens in a recombinant haplotype designated B -Ir-GAT-Lo. In addition, 
normal viability and immune response have been linked to B^ SD erythrocyte 
antigens in a recombinant haplotype designated B^-Ir-GAT-Hi (Pevzner et 
al., 1978; Lee and Nordskog, 1981). 
Line 19, an inbred White Leghorn line, segregates for three B 
haplotypes with serological markers b"^, B^ and B^; IVhite Leghorn line HN, 
an inbred derived from a Heisdorf-Nelson importation, has been maintained 
E F 1 
as a population segregating for B , B and B . Line M, an inbred Fayoumi 
Y 2 1 line, segregates for B , B and B . The letter superscripts are tempo­
rary designations and will eventually be replaced by numbers as informa­
tion accumulates. Serological information suggests the following 
identities: b'^=B^^, B^=B^^'^, B^=B^^, B^=B^^, B^=B^^*^, and B^=B^. 
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Blood Typing Reagents 
B system alloantisera were produced by various protocols. Injection 
of 1-2 ml of freshly collected whole citrated blood on days 1 and 1, 
followed by collection of plasma in heparin on day 13, proved to be an 
effective scheme. The minimal amount of stimulation produced highly 
specific reagents; absorptions were generally not used. 
Skin Grafting Procedure 
Several layers of collodion were applied to the back skin of each 
bird and allowed to dry. Full thickness pieces of skin, 1 cm square, were 
then cut out to supply donor grafts and to form recipient transplantation 
beds. Donor skin was kept on filter paper moistened with phosphate buf­
fered saline (PBS) until transplanted to a recipient. Rotating the graft 
180° prior to transplantation aided in recognition of successful grafts 
by noting the reversed direction of feather growth. Grafts were held in­
tact with adhesive bandages which were removed on day 7 post-grafting. 
Arbitrary scores (Table 1) were assigned to the grafts to indicate 
graft condition (Polley et al., 1960). Grafts were first scored on day 7 
posttransplantation followed by several consecutive scoring days, but 
with decreasing frequency after this initial period. 
Table 1. Scoring system to judge allograft condition 
Score Appearance of Graft 
5 Healthy 
4 Slight evidence of inflammation 
3 Erythematous and slightly shrunken 
2 Brownish and erythematous or shrunken 
1 Black and shrunken or detached from host 
integument 
0 Graft sloughed 
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Graft-Versus-Host Splenomegaly 
A 1 cm square area was outlined on the shell over a large straight 
vein of the allantoic membrane of a day 13 embryonated egg. On day 14, 
donor blood was collected aseptically; the lymphocytes were isolated by 
the slow spin method or by the ficoll-hypaque gradient technique. The 
lymphocytes were washed three times in Hank's balanced salt solution and 
the concentration standardized to 2 x 10^ cells/ml. The 1 cm square area 
of day 14 embryos was swabbed with iodine, the shell was cut along the 
outline with.a moto tool (Premel Mfg., Racine, Wis.), and the shell frag­
ment was carefully removed leaving the shell membrane intact. Each embryo 
was injected intravenously with ,1 ml of donor blood using a 27 gauge 
needle. The shell hole was covered with masking tape and sealed with 
melted paraffin. On day 19 of incubation, the spleen was dissected from 
the embryo and weighed on an analytical balance. 
Mixed Lymphocyte Reaction 
Blood was collected aseptically in heparin from adult chickens. 
Lymphocytes were separated by the slow spin method and washed three times 
in culture media. The lymphocytes were adjusted to a concentration of 
1,5 X 10^ cells/ml in Iscove's modified Dulbecco's media (430-2200, Gibcoî 
-5 
supplemented with 7.5 x 10 M monothioglycerol, 500 yg/ml gentamycin, 4 
vg/ml bovine serum albumen (.Cohn fraction V, Sigma) , 1 ]ig/ml human trans­
ferrin, 110 mg/1 sodium pyruvate, and 1 mg/1 reduced gluthathione. 
Twenty pi aliquots of cell suspension were mixed in the wells of 
round bottom tissue culture plates (76-013-05, Linbro). Because the 
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volumes were small, the plates were sealed with tape to minimize evapora­
tion; a small opening allowed gas exchange. The final volume in each well 
was 40 pi containing 3 x 10^ cells. 
Plates were incubated at 41.5° C for 72 hours in a 5% CO^ in air 
atmosphere. After addition of .5 yCi ^H-thymidine to each culture in 20 
pi mediaf they were incubated for an additional five hours. The cells 
were harvested on glass fiber filters in a cell harvester (CH-103, Dyna-
tech); the filters were dried at 130" C for one hour and counted in a 
Betacounter in Aquasol-2 (New England Nuclear) for one minute. 
Hemagglutination Assay 
B blood group alloantisera were added to the wells of round bottom 
plates (76-311-05, Linbro) in 50 pi aliguots. Two percent suspensions 
prepared from erythrocyte samples were added in 50 pi volumes to the wells 
containing the appropriate reagents. The plates were shaken for five 
minutes on a Microshaker II (Dynatech) and allowed to stand for one hour 
at room temperature. Agglutination reactions were assigned scores as in­
dicated in Table 2. 
Table 2. Scoring system of hemagglutination reactions produced with B 
blood group alloantisera 
Score Pattern 
4 Mat, no sedimentation 
3 Mat, slight sedimentation 
2 Mat, moderate sedimentation 
1 Pellet, irregular edges of agglutinates 
0 Pellet, round, no agglutinates 
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Triple Hemagglutination Test 
The B complex contains at least two loci coding for erythrocyte cell 
surface antigens, B-G and B-F. Gene products of these loci are polymor­
phic and detectable in a hemagglutination assay. To obtain recombinants 
of B-G and B-F alleles, B heterozygotes were mated to homozygotes of a 
third B allele, and the progeny were tested by hemagglutination with B 
system alloantisera. The assumption is that each antiseirum recognizes 
both a B-G and a B-F region gene product of a parental haplotype. Recom­
binants of B-G and B-F region alleles should then react with antisera 
specific for each of the three alleles in the mating that produced it 
(Table 31. 
Table 3. Triple hemagglutination test, for the detection of recombinants 
Haplotype s Alleles Reagents 
G,F/G,F Anti-B-1 Anti-B-2 Anti-B-19 
CG1,F1). . (G2,F2) (G19,F19) 
Parental 
1,1/2,2 + + 
B^B^^ 2,2/19,19 + + 
B^B^® 1,1/19,19 + + 
Heterozygous 
recombinant 
B^"^V 1,19/2,2 _ 
Bl-2gl9 1,2/19,19 
b2-19B1 2,19/1,1 
19,1/2,2 
IS 
2,1/19,19 
2,19/1,1 
19,2/1,1 
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Immunofluorescence 
Lymphocytes, collected from fresh heparinized blood by the slow spin 
method, were suspended in PBS containing .1% sodium azide and 2% fetal 
calf serum (FCS) at a concentration of 5 x 10^ cells/ml- Ten yl of B 
blood group alloantisera mixed with 10 pi of cell suspension were incubated 
on ice for 20 minutes. The cells were washed twice with the PBS-azide-
FCS, suspended in 20 jjl of fluorescein labelled rabbit-anti-chicken IqG, 
and incubated on ice for 20 minutes. The cells were again washed twice 
in PBS-azide-FCS and suspended in 20 y 1 of 70% glycerol. The cells were 
observed for fluorescence with a Leitz Ortholux II microscope fitted with 
a 54x or 63x objective. 
GAT Response Assay 
Chickens were immunized intramuscularly with 1 ml of an emulsion of 
conplete Freund's adjuvant and PBS (pH 7.2) containing 100 jig GAT (L-
glutamic acid^^, L-alanine^^ and L-tyrosine^^, Miles, Elkhart, Ind.) and 
boosted with 100 pg GAT in 1 ml of PBS on day 21. Serum samples were col­
lected on days 14 and 28. Twenty yl samples of test or control serum 
were mixed with 180 yl of PBS containing 1% normal chicken serum. After 
addition of 25 y 1 of a dilution of iodinated GAT to each sangle, they were 
kept at 4° C for one hour. Fifty yl of rabbit-anti-chicken IgG were then 
added to each sample. After one hour of incubation at 4° C the samples 
were centrifuged at 6500g for 10 minutes. Fifty yl of supernatant were 
then withdrawn from each sample and counted in a gamma counter (Tracor ^ 
Analytic, Model 1197) for two minutes. The percent antigen bound was 
determined as 
18 
100 (1 - test sample CPM ^ 
control sample CPM 
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RESULTS 
Production of B Complex Recombinants 
Matings to produce serological recombinants in 1980 are described in 
Table 4. Three thousand, five hundred ninety-two progeny were produced 
from these matings. Based on a triple hemagglutination test, four of 
these were designated putative recombinants (Table 5) including; (a) a 
chicken of line 19 which proved to be an intersex, Cb) two line HN males 
and (c) one line SI female. Backcross matings to test for recombinant 
haplotypes are described in Table 6. 
A bird from Leghorn line 19 giving triple reacting erythrocytes 
(wing band number 8537) was first recorded as a female but later developed 
features characteristic of a male. At maturity, this bird had well-
developed spurs and pointed hackle and saddle feathers; yet its vocaliza­
tions were typically female. It neither produced semen nor laid eggs. 
Possibly an unbalanced chromosome constitution, such as polysomy or poly­
ploidy, is the cause of both the red cell triple reactivity and the ste^ 
rility of this bird. It has been judged not to be a recombinant. 
The erythrocytes of a line HN male (wing band number 7333) gave 
strong reactivity with anti-B-E and anti-B-F and weak reactivity with 
anti-B-1 reagents. Because he transmitted the B^ and B^ haplotypes, but 
not B^ to his progeny, this bird was deduced to be a B^B^ heterozygote. 
Weak cross reactions of the anti-B-1 reagents rather than recombination 
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Table 4. Matings to produce serological recombinants and the number of 
putative recombinants obtained from each single male mating 
(1980 hatching season) 
Female Number Number Putative Putative 
Blood Type Progeny Recombinants Genotype 
Typed (Wing Band Number) 
Line Male 
Blood Type 
M 
19 
HN 
SI 
sV 
BV 
BV 
bV 
BV 
bV 
BV 
BV 
BV 
BV 
BV 
B^B^ 
BV 
B^V  ^
BV 
BV 
bV^ 
Blgl* 
Y Y B B 80 
1 Z B B 211 
Z Z B B 29 
1 Y 82 B B 
402 
1 L 35 B B 
L L B B 273 
BV 203 
J L B B 129 
640 
1 1 B B 109 
F F 418 B B 
E E B B 110 
E F B B 193 
830 
2 19 267 B B 
1 19 B B 218 
BV 234 
_19_19 8 B B 
_19_19 
205 B B 
2 2 B B 381 
2 2 B B 176 
1 1 B B 231 
1,720 
1(8537) 
1(7333) 
1 (3878) 
1(13777) 
B^-V 
B^-V 
TOTAL 3,592 
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are the most likely ej^lanation for his erythrocytes to react with all 
three test antisera. An alternative possibility is that his blood cells, 
but not his gonads, were chimeric. 
Table 5. Triple hemagglutination test pattern of red cells from putative 
recombinants (1980 hatching season) 
Line Cross Wing Band Agglutination Score— 
Number First Typing 
Anti-B- J J J L L L 1 1 
19 B"^B^ X B^B^ 8537 4 4 4 3 3 3 4 4 
Anti-B- E E E F F 1 1 1  
HN B^B^ X BV 7333 2 4 4 4 4 1 1 1  
Anti-B- E E F F F 1 1 1  
HN sV  X B=B= 3878 4 4 2 2 2 4 4 4 
Anti-B- 1 1 1 2 2 19 ^  19 
SI B B X B B 13777 2 2 2 4 4 0 2 1 
A male of line HN (wing band 3878) produced 274 progeny. The data 
indicated he repeatedly transmitted three alleles, as judged by progeny 
testing with anti-B-E, anti-B-F and anti-B-1 reagents. Because this male 
transmitted normal B alleles to its progeny, the likelihood that he car­
ried a recombinant haplotype seemed nil. Silver staining of the B-linked 
nucleolar organizer region, kindly performed by courtesy of Dr. S. E. 
Bloom of Cornell University, proved that this bird was disomic and not 
trisomie. Very likely, the red cells and gonads of this bird were chimeric, 
possessing two populations of cells with distinct genotypes. Such a 
chimera has been previously reported in chickens by Halà et al. (1978), 
Table 6. Backcross tests of four putative recombinants produced (1980 hatching season) 
Line Wing Band Sex Putative Crossed Progeny 
Number Genotype With Blood Type Number of Progeny 
HN 7333 Male B^B^ B^B^ 3 
B^B^ 1 
B^B^ B^B^ 19 
B^B^ 14 
B^B^ B^B^ 4 
B^B^ 8 
BV sV 5 
6 
B^B® 8 
10 
78 
1-P E FF E F 
HN 3878 Male B B B B B B 73 
B^B^ 39 
B^B^ 34 
B^B^ 0 
BV 1 
B^B^ B^B^ 26 
B^B^ 27 
B^B^ 18 
19 8537 Inter-sex 
SI 13777 Female B^"^^B^ 
(Bl9rl) 
Blgl 
BV 
B^Bl 
sV 
BV 
BV 
Blgl 
BV 
BlgG 
16 
13 
1 
15 
2 
6 
2 
1_ 
274 
B^B^ 
BV 
0 
0 
Efs: 
Efs: 
B^B: 
B^Bl* 
36 
26 
1 
1 
64 
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who described a male with red cells of two distinct B genotypes and which 
transmitted three B haplotypes to its progeny. 
2 2 SI female 13777, mated to a B B male, produced 64 progeny classified 
either as B^B^ or B^ ^ ^B^ (Table 3). The test of a two-allele 
hypothesis for a 1:1 segregating ratio gave a satisfactory fit to the data 
19 
at the 5% significance level, confirming that a recombinant of the b1 and B 
haplotypes had been produced. However, two progeny with unexpected blood 
12 2 19 
types, B B and B B , were identified in this group. Because a female penned 
2 19 
with 13777 had been producing B B chicks, and because a farm worker may 
have erred as to the parentage of eggs laid before the hens were accustomed 
2 19 to the use of trap nests, the B B chick was judged a pedigree error. 
1 2 
In a later hatch, a chick typed as B B may also have been a pedigree error. 
In 1981, further matings were set up between birds in the SI line 
in order to produce additional serological recombinants. The design of 
these matings is given in Table 7. Of 1,992 progeny tested, 4 were posi­
tive using the triple hemagglutination test; these were classified as 
2 2 putative recombinants (Table 8) . All were produced from matings of B B 
males to B^B^^ heterozygous females. The putative B^ ^^B^ birds were 
2 2 2 
mated to B B homozygotes in a backcross test (Table 9). Ax test of 
the hypothesis for two-alleles segregating in a 1:1 ratio gave a satis­
factory fit to the data at the 5% level of significance for each of the 
four birds tested. 
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Table 7. Matings to produce serological recombinants and the number of 
putative recombinants produced in each single-male mating (1981 
hatching season) 
Male Blood Female Blood Number of Progeny Number of Putative 
Type Type Typed Recombinants 
BV 348 1 
B^B^^ 318 1 
sV BV" 245 0 
BV BV" 341 0 
BV BV^ 306 2 
BV 41 0 
BV 5,1*819 32 0 
B^BlS B^B^ 329 0 
B^Bl* B^B^ 32 0 
Total 1,992 4 
Table 8. Triple hemagglutination test pattern of red cells from four SI 
putative recombinants produced from x B^B^ matings (1981 
hatching season) 
Wing Band 
Number 
Sex Agglutination Score-First 
Typing 
1547 
1779 
6093 
12610 
Male 
Male 
Male 
Female 
Anti-B- 1 1 1 2 19 19 
4 4 4 4 4 4 
4 4 4 3 1 4 
4 4 4 4 0 4 
4 4 4 4 4 4 
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Immunofluorescent Analysis of the 
Recombinant Haplotypes 
1 19 
The tissue distribution of the B and B antigens on the recombinant 
haplotypes was determined by immunofluorescence. Results are given in 
Table 10. The anti-B-1 serum stained red cells only and the anti-B-19 
2 
serum stained both red cells and lymphocytes of the recombinant-B hetero­
zygous birds. Because B-G antigen is found on red cell membranes but not 
lyn^hocyte membranes, the evidence indicates that the recombinant haplo­
types each must have derived their B-G region from the B^ parental haplo-
type. On the other hand, because the B-F antigen is found on both red 
cell and lymphocyte membranes, the recombinant haplotypes must have de-
19 
rived their B-F region from the B parental haplotype. Accordingly, the 
^ T- ^ J • ^ ^ _19rl ^19r2 „19r3 ^19r4 
new recombinant haplotypes were designated B , B , B , B , 
and (Tables 6 and 9). Because the anti-B-2 reagents stained red 
cells and not lymphocytes, they apparently recognized the B-G antigen only. 
1—19 2 2 2 
Table 9. Backcross tests (B B x B B ) of four SI putative recombinants 
produced (1981 hatching season) 
Wing Band Progeny Revised Haplotype 
Number Blood Type Number Designation 
1547 B^~^®B^ 65 B^®^^ 
B^B^ 62 
1779 40 B^^^^ 
B^B^ 33 
6093 B^"^®B^ 60 
B^B^ 53 
12610 B^~^®B^ 4 B^^rS 
3 
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Table 10. Immunofluorescent staining of red cells and lymphocytes from 
birds carrying the haplotypes glSrS^ B ^ , and 
Bl9r5 
Test Cells of Genotype Type of Fluorescence 
Bird Number Cells Anti-B-1 Anti-B-19 Anti-B-2 
12139 BV WBC + - -
12092 B^B^ WBC + - -
12046 WBC - + -
11817 WBC - + -
6535 BLSRLGZ WBC — + -
6529 B^^V WBC — + -
6993 WBC — + -
6531 B^^V WBC — + -
1547 WBC — + -
1779 WBC - + -
6093 WBC — + -
12610 WBC - + + 
12092 B^B^ RBC + - + 
11817 SBC - + + 
6529 RBC - + + 
6531 RBC — + + 
1547 RBC — + + 
1779 B^^V RBC — + + 
6093 B^9r4g2 RBC — + + 
12610 B^^V RBC — + + 
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GAT Response Analysis of the 
Bl9rl Haplotype 
19rl 
Results of testing B homozygous birds for immune response to GAT 
are given in Table 11. Sera were collected on day 14 (primary) and day 
28 (secondary) after the primary immunization. In both the primary and 
19rl 
secondary responses, the B homozygotes were high responders to GAT. 
19rl Several days prior to testing the B homozygotes, the same batch of 
GAT was used to measure the immune response of another group of chickens. 
The average response of 96 birds classified as Ir-GAT-Hi responders was 
36.4. Seventy-four birds classified as Ir-GAT-Lo responders gave responses 
19rl 
near zero. Because the B homozygotes consistently gave a high immune 
response to GAT, the conclusion was that this haplotype contains the Ir-
GAT-Hi gene. 
19rl 
Table 11. Test of B homozygous birds for immune response to the 
synthetic polypeptide GAT 
Genotype Primary Response Secondary Response 
(Number) (Number) 
74.4(14) 51.4(14) 
Skin Transplantation Analysis of the 
Bl9rl Haplotype 
The results of two skin grafting experiments using backcross 
progeny are given in Table 9. Typically B-incompatible grafts are re­
jected and B-compatible ^afts are intact at 10 days post-grafting using 
14-day old chicks. Graft exchanges among 6- and 10-week old chicks in 
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Table 12 gave earlier rejection than expected. For example, only one of 
11 12 2 2 
seven B B, control grafts on B B recipients and three of nine B B control 
1 2 grafts on B B recipients were intact 10 days post-grafting. The use of 
older birds for grafting in this experiment probably accounts for the 
earlier rejections. Exchanges among two-week old birds, presented in 
Table 13, are more in accord with expectation. That is, B-compatible con­
trol grafts were largely intact and B-incompatible control grafts were 
mostly rejected at 10 days post-grafting. 
19rl Of special interest were graft exchanges involving the B haploytype. 
19rl 2 12 
As given in Tables 12 and 13, B B grafts on B B recipients were re­
jected (zero of nine and zero of six, respectively) at 10 days post-
grafting. Most B^B^ and B^B^ grafts on B^^^^B^ recipients were rejected 
(seven of eight and five of five, re^ectively) and the majority of B^^B^^ 
2 19 19rl 2 
and B B grafts on B B recipients were accepted (six of ten and six 
of six , respectively) at 10 days post-grafting. These results demonstrate 
a strong histocompatibility difference between the B^^^^ and B^ haplotypes. 
On the other hand, no evidence for a histocompatibility difference could 
19rl 19 be detected between the B and B haplotypes. 
Graft-Versus-Host Analysis of the 
Bl9rl Haplotype 
Results of three replicates of a graft-versus-host ^lenomegaly test 
are given in Table 14. gl9rlg2 lymphocytes injected into B^B^^ embryos 
produced spleen enlargement significantly greater than controls but when 
gl9rlg2 2yi[çhocytes were injected into B^B^^ embryos no spleen enlargement 
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Table 12. Survival of skin grafts exchanged to determine whether major 
histocompatibility differences exist between the B^Stl haplo-
type and the and B^® parental haplotypes (Experiment 1) 
Time Donor Recipient Genotype 
Genotype b^2 52*19 BV 
BV 
(Accepted/Total) 
10 days 5/6 
1/8 
0/9 
1/7 
6/8 
0/8 
0/8 
1/9 
B^B^ 4/7 3/9 8/10 7/9 
B^V® 6/10 0/9 7/9 0/10 
25 days 2/6 0/9 3/8 0/8 
B^B^ 0/8 0/7 0/8 0/9 
B^B^ 4/7 3/9 4/10 3/9 
B^V^ 0/10 0/9 3/9 0/10 
Table 13. Survival of skin grafts exchanged to determine whether major 
histocompatibility differences exist between the B^^^^ haplo-
type and the and parental haplotypes (Experiment 2) 
Time Donor Recipient Genotype 
l" 2 2 1 
B B B B B~B 
Genotype gl9rlg2 _1_ _ _ 9 _1_19 
(Accepted/Total) 
10 days B B~ 5/5 0/6 6/6 0/5 
0/6 
0/5 
2/6 
25 days B B~ 4/5 0/6 5/6 0/5 
0/6 
0/5 
2/6 
B^sf 0/5 5/6 0/6 
B^B^S 6/6 0/6 6/6 
BV^ 0/6 1/6 0/6 
BV 0/5 3/6 0/6 
BV" 
5/6 0/6 6/6 
0/6 0/6 0/6 
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could be detected. Again, major histocompatibility differences between 
the and B^ haplotypes were indicated. B^B^^ lymphocytes injected 
into B^B^ embryos produced significantly greater splenomegaly than B^^^^B^ 
1 2 lymphocytes injected into B B embryos. This suggests that both "ends" 
of the chromosome segment, representing the B complex, contribute to the 
graft-versus-host reaction. Interestingly, Lee and Nordskog (1981) ob-
11 19 19 
served that B B lymphocytes cause greater enlargement of B B spleens 
19 19 11 than B B lymphocytes in B B spleens. In the present ei^eriment, 
2 19 12 
enlargement of B B spleens produced by B B lyitghocytes was significantly 
greater (P < .01) than the reciprocal test. 
Table 14. Mean spleen weight (mg) produced by graft-versus-host 
splenomegaly reactions involving the B^^^^ haplotype 
Donor Genotype Recipient Genotype 
BV 
1 2 (3) B B 19.0 + 10.5 ** 85.2 + 3.6 (25) 
** ** 
5=519 51.4 
* 
+ 4.3 (18) ** 15.2 + 3.9 (21) 
40.3 + 3.7 (24) ** 16.1 + 2.5 (52) 
* Significant at the .05 level. 
** Significant at the .01 level. 
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Mixed Lymphocyte Reaction Analysis 
of the Haplotype 
Results of a two-way mixed lymphocyte reaction test are given in 
Table 15. Such a test, using lymphocytes of and B^B^^ individuals. 
gave no increase in counts per minute over the negative (B-compatible) 
19rl 2 12 
control, but for a test using lymphocytes of B B and B B , a highly 
significant increase in counts per minute was found relative to the nega­
tive control based on the Student's t test. Because the mixed lymphocyte 
reaction is mediated by la antigens in the mouse, this suggests a major 
difference in la-like antigens between the B^^^^ and B^ haplotypes in the 
chicken. 
Table 15. Results of two-way mixed lymphocyte reactions between the 
gl9rl haploytype and its two parental haplotypes, B^ and B^^ 
Cells Counts Per Minute Number of Birds, Wells 
B^B^. B^B^* 1,651 + 101 8, 48 
** 
IQ-rl 2 12 
B B • B E 1,418 + 101 8, 48 
** 
B^^^^B^ • B^B^® 183 + 50 8, 48 
Bl9rlg2 ^ gl9rlg2 133 + 50 4, 12 
B^B^. B^B^ 218 +50 4, 12 
2 19 2 19 
B B . B B 197 + 50 4, 12 
** Significant at the .01 level. 
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Each lymphocyte suspension was paired with both a B-compatible and a 
B-incompatible suspension. The ratio of counts per minute for each B-
incompatible pair to the average count per minute of the two corresponding 
B-compatible pairs was then calculated. An analysis of variance was made 
on the log-transformed values. The assumption was that test samples and 
plates were random effects and sets and duplicate pairs were fixed effects. 
The analysis of variance, presented in Table 16, revealed that four factors 
significantly affect the mixed lymphocyte reaction: (1) experiment/ 
(2) replication, (3) genotype pair (Set), and (4) duplicate pairs. 
Estimated variance components and percentages were also calculated (Table 
15). These results demonstrate that most of the variation is associated 
with experiment and replication differences. 
Table 16. Analysis of variance for the mixed lymphocyte reaction 
experiments 
Source of 
Variation D.F. S.S. M.S. E.M. s. 
Variance Variance 
Component Component 
(%) 
EXPERIMENT (E) 1 52.69 52.69** 2 
^e 
+ 
^4 26.004 82.0 
KELICATE (R)/E 2 32.85 16.43** 2 
^e 
+ 4a^ 3.937 12.4 
SET {S)/R/E 8 49.59 6.20** 2. 
^e 
+ 12c^ 0.460 1.5 
DUPLICATE 
(D)/S/R/E 12 192.63 16.05** 2 % + 0.641 2.0 
Error 120 81.42 0.68 2 a 
e 
0.678 2.1 
Total 
(corrected) 143 409.18 
** Significant at the .01 level. 
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Skin Transplantation Analysis of the 
gl9r2^ gl9r3 and Haplotypes 
Results of two replicate tests of a skin transplantation eiq^eriment 
19r2 19r3 19r4 between individuals representing B , B and B haplotypes are 
2 given in Table 17. All birds with recombinant haplotypes were B hetero-
2 2 
zygotes. At 10 days post-grafting, B B birds rejected all grafts from 
birds bearing the recombinant haplotypes. In contrast, recipient 
2 2 2 
recombinant-B heterozygotes did not reject B B grafts except for a few 
exceptions. Grafts exchanged within and between the different recombinant 
haplotypes were largely intact at 10 days post-grafting suggesting that 
the three recombinant haplotypes bear identical major histocompatibility 
alleles. 
Table 17. Survival of skin grafts exchanged to determine whether major 
histocompatibility differences exist between the B^®^^ 
and B^®^^ haplotypes 
Time Donor Recipient Genotype 
Genotype 
B^^V sV 
10 days 15/16 13/16 15/16 0/13 
14/16 14/14 16/16 0/15 
15/16 14/16 16/16 0/16 
B^B^ 15/16 14/14 16/16 15/16 
25 days 15/16 11/16 15/16 0/13 
14/16 13/14 16/16 0/15 
14/16 11/16 16/16 0/16 
BV 15/16 13/14 16/16 14/16 
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Recombination Frequency Within 
the B Complex 
Observed recombination frequencies between the B-G and B-F loci are 
given in Table 18. The recombination frequencies did not differ signifi-
2 
cantly between experiments when tested with the x test for the Poisson 
distribution (Snedecor and Cochran, 1957). Because B antigens may not 
have reached adult levels, certain otherwise detectable recombinants may 
not have been detected in these experiments. Experiment 1 chicks were 
typed at four weeks of age and Experiment 2 chicks were typed at six weeks 
of age. Possibly the typing of birds at an early age in Ei^eriment 1 may 
account for the lower estimate of frequency of recombination. All recom-
1 19 binants detected involved B B heterozygotes although other heterozygote 
combinations were tested. Also, the reagents used to detect recombinants 
did not necessarily recognize both the B-G and B-F loci. 
Table IS. Estimates of recoinbination frequencies from .Experiments 1 and 2 
Group Nimiber Recombinants/ Frequency of 
Number Tested Recombination (%) 
Eîçeriment 1 1/3592 .028 
Experiment 2 4/1992 .201 
Ej^eriment 1 and 2 average 5/5584 .090 
Heterozygous Females 4/2927 .137 
Heterozygous Males 1/2657 .038 
B^^^ Heterozygotes 5/2333 .214 
All Other Heterozygotes 0/3251 .000 
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DISCUSSION 
Linear Order of Genes 
The primary purpose of this study was to identify and characterize 
recombinants of B complex genes which code for serologically detectable 
cell surface cd.loantigens. Recombinants are e^ecially useful in deter­
mining the gene con^lexity and ultimately the linear order of genes on a 
chromosome segment. Five birds, seemingly bearing recombinant haplotypes as 
determined by a triple hemagglutination assay, were verified as true re-
19rl 
combinants in backcross tests. One of these, B , has been further 
studied with respect to alloimmune properties and immune responsiveness. 
The others hopefully will be analyzed further at a later date. 
The B complex has been associated with a chromosome in the size range 
of 15-18 (Bloom and Cole, 1978). The current model of the B complex, 
proposed by Vilhelmovâ et al. (1977) , is given in Figure 1. The order of 
the loci and their position relative to the centromere has not been deter­
mined. The B-G and B-F regions were separated by a crossing over event 
and the resulting recombinant was detected by hemagglutination. The B-G 
region, coding for an erythrocyte alloantigen, has no known function. 
The B-F region, coding for a protein homologous to the murine K and D 
antigens, controls histocompatibility. The B-L antigens, dimers of poly­
peptides believed homologous to the o and 3 chains of murine la molecules, 
are coded by the B-F region. 
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Region: B-F B-G 
Locus: 
Molecular 
Weight: 
B-F 
42K 
B-L 
27K 
B-L 
33K 40-43K 
B-G 
Figure 1. Model of the B complex proposed by Vilhelmovà et (1977) . 
Dashed line indicates region of crossing over. The B-L mole­
cules are dimers of polypeptides presumably coded by distinct 
structural genes. Molecular weights are determined by Ziegler 
and Pink (1975, 1976), Kvist et al. (1978) and Brogren and 
Bisati (1980) 
A chromosome segment containing the B-G and B-F loci has been 
separated from the Ir-GAT locus and recovered in recombinant form as re­
ported by Pevzner et al. (1978) and Lee and Nordskog (1981). Their studies 
suggest that the Ir-GAT locus occupies an end position of the B complex. 
In the present study, the B-G and B-F genes were separated in each of five 
19rl independent recombination events. The first recombinant, B , has now 
19rl been produced in homozygous form. B homozygotes have proved to be 
high responders to the synthetic polypeptide GAT; therefore, this haplo-
19 
type is deduced to contain the Ir-GAT-Hi gene of the B parental haplo-
type, Immunofluorescent testing indicates that the B-G gene was derived from 
1 19 
the B parental haplotype and the B-F gene from the B parental haplo-
type. Therefore, the B-F and Ir-GAT genes both must be contained in a 
19 
chromosome segment derived from the B parental haplotype. Evidently, 
the B-G locus also occupies an end position of the B complex. The combined 
results suggest that the order of the genes is B-G, B-F and Ir-GAT. 
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In the mouse, experiments have provided evidence that the immune 
response gene products are the la antigens themselves (Benacerraf, 1981). 
The arguments for this are; (a) la antigens and immune response genes map 
in the same suhregions of the H-2 complex, (b) monoclonal antibodies to 
la antigens, when bound to antigen-presenting cells, specifically block 
in vitro responses to antigen and (c) studies of complementation by and 
A and E and E. polypeptides reveal a close relationship between chain 
p 01 p 
structure and the genetic control of immune responsiveness to synthetic 
polypeptides. 
Others in this laboratory, working with B complex parental and 
recombinant haplotypes involving loci coding for SD erythrocyte alloanti-
gens and the Ir-GAT locus, have provided data showing that the immune 
response region containing the Ir-GAT locus controls the production of 
antigens homologous to the murine la antigens as regards both tissue dis­
tribution and molecular weight (R. C. Birkmeyer and A. W. Nordskog, 
Department of Animal Science, Iowa State University, unpublished). 
These antigens almost certainly are equivalent to the B-L antigens 
identified by Ziegler and Pink (1976). The functional homologies 
of the chicken B complex to the murine H—2 coirç)lex lead to the conclusion 
that the Ir-GAT locus is identical to a B-L locus. First, the Ir-GAT 
locus controls immune responsiveness. Secondly, a B-L locus controls the 
production of molecules homologous to murine la antigens in molecular 
weight, ontogeny of cellular expression and in tissue distribution (Ewert 
and Cooper, 1982), Thirdly, immune response genes (Ir-GAT) and genes 
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coding for molecules homologous to the murine la antigens (B-L) have not 
been separated by crossing over. Therefore, identity of the Ir-GAT locus 
and a B-L locus must be assumed, which leads to the proposal of a new 
model for the B complex (Figure 2). Blocking of ^  vitro responses to 
GAT by binding specific monoclonal antibody to the B-L antigens on antigen-
presenting cells would provide final evidence for the common identity of 
the Ir-GAT locus and a B-L locus. 
Region: ^ B-L — B—F B—G ^ 
Locus : 
Molecular B-L B-L B-F B-G 
Weight: 27K 33K 42K 40-43K 
Figure 2. Proposed order of loci for the B complex. Dashed lines indicate 
regions of crossing over. The B-L molecules are dimers of 
polypeptides presumably coded by distinct structural genes 
Recent biochemical evidence now reveals two populations of molecules 
which are homologues of murine la molecules (Crone et al., 1981). 
The location within the B complex of genes coding for these molecules can 
be inferred. One population of molecules is likely coded by the Ir-GAT 
locus or by a locus linked closely to it. Because the graft-versus-host 
reaction is controlled by la antigens in the mouse, and because the 
chromosome segment containing the B-G and B-F genes exerts a major in­
fluence on graft-versus-host reactivity, a second population is likely 
coded by a gene closely linked to B-F. In addition, the B con^lex controls 
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total hemolytic complement activity (Chanh et al., 1976). This is 
assumed to involve a locus (loci) controlling variant forms of a comple­
ment component(s) within the B complex. In addition, Schierman et al. 
(1977), Collins et al. (1977) and Gebriel et al. (1979) all provided evi­
dence for a locus with alleles conferring resistance (Rs) and suscepti­
bility (rs) to tumors induced by the Bryan strain of Rous sarcoma virus. 
Taking these findings into account, a theoretically more complete model 
of the B complex is proposed (Figure 3) . 
Region: • B—L ————— B"F —— —• • B~G ; 
(Ir-GAT) . 
Locus: Rs,rs? B-L(l) B-L(2) B-F B-G C4? 
Figure 3. Theoretical model of the B complex. Dashed line indicates 
region of crossing over. The existence of B-L(2) is inferred 
because of biochemical evidence for two populations of la-like 
molecules and because the B-F region as defined by studies in 
this laboratory controls graft-versus-host reactivity. B-L(l) 
and B-L(2) each represent two structural genes coding for 
polypeptides that form dimers 
Several problems arise in the interpretation of the immune response 
data. In the mouse, la antigens are dimers of molecules coded by two 
distinct genes. At least four structural genes have been identified: 
A , A-, E and E„. The A molecules are dimers of A and A„ and the E O p Ot p Op
molecules are dimers of E and E_ polypeptides. Low immune response could 
a p 
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result from the lack of expression of one or both of the A or E molecules 
(Klein et al., 1981). 
The identification of immune response gene products using siinple 
serological tests is of obvious usefulness. In the chicken, at least two 
populations of B-L molecules have been reported (Crone et al., 1981) . Low 
immune response to GAT could be attributed to the lack of expression of 
one or both of the structural genes for a dimer. If neither structural 
gene coding for a dimer conferring responsiveness is expressed, three 
types of nonresponder recombinant haplotypes could be produced from the 
original nonresponder haplotype. This can theoretically occur because 
recombinant haplotypes will be nonre^onders whether they contain either 
one or both of the genes which are not expressed. 
Alloimmune Properties 
According to Vilhelmovâ et al. (1977), the mixed lymphocyte reaction, 
skin graft rejection and graft-versus-host reactivity are controlled by 
the B-F region of the B coirplex. Because the B-F region, as defined in 
their studies, is presumed to contain both the B-F and B-L loci, the 
determination of the properties controlled separately by the B-F locus and 
by the B-L locus has, so far, not been reported. 
For recombinants reported more recently (Pevzner et al., 1978; 
Lee and Nordskog, 1981), the Ir-GAT gene, presumed to be a B-L gene, has 
been separated from a chromosome segment containing the B-G and B-F genes, 
The Ir-GAT locus seemed not to influence skin graft rejection and had only 
a minor influence on the graft-versus-host reaction when compared with 
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the region containing the B-G and B-F genes. Because the graft-versus-
host reaction is controlled by la antigens in the mouse, and because the 
chromosome segment containing the B-G and B-F genes exerts a major in­
fluence on graft-versus-host reactivity, it is yet unclear whether the 
chromosome segment containing the B-G and B-F genes contains an unidenti­
fied B-L gene(s). If so, it must be linked closely to B-P between the 
B-G and Ir-GAT genes. 
The relatively minor influence of the Ir-GAT locus on the graft-
versus-host reaction contrasts with the strong influence of the H-2 immune 
response genes on this phenomenon. A possible explanation is that the 
different gene products of this locus are structurally very similar or 
that Ir-GAT-Lo responders result from the lack of expression of a struc­
tural gene. Lee and Nordskog (1981) pointed out that the relative 
contribution of the B-F and Ir-GAT regions may depend on the position of 
the chromosome break point. Their interpretation assumes that the B-F 
region, as defined in their study, contained more loci than the Ir-GAT 
region and that the additional allelic differences resulted in the in­
creased graft-versus-host reactivity. Additional studies are needed to 
determine which interpretation, if any, is correct. 
In the present study, the mixed lymphocyte reaction, skin graft 
rejection and the graft-versus-host reaction were all controlled by the 
19rl 
chromosome segment within the B haplotype containing the B-F and Ir-
GAT genes. These functions appeared not to be controlled by the B-G 
locus. In summary, the information discussed here supports the conclusion 
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that the Ir-GAT region has a minor influence on graft-versus-host 
reaction; the B-F region controls the mixed lymphocyte reaction, graft-
versus-host reaction, and skin graft rejection; and the B-G region controls 
none of these. Additional recombinants must be produced before these 
functions can be assigned to the Ir-GAT and B-F genes. Because the number 
and nature of genes contained within the regions defined in this study and 
previous studies are unknown, the mammalian model has been used to allow 
inferences as to which properties are controlled by the different classes 
of genes in the B complex. In particular, the assumption is that B-F 
genes control skin graft rejection and B-L genes control mixed lyzghocyte 
reaction and graft-versus-host reaction. Functional properties of the 
B-G locus cannot be inferred because no mammalian homologue has been dis­
covered. 
Recombination Frequency 
The combined estimate of the recombination frequency of B—G and B-F 
from Experiments 1 and 2 is 5/5,584. This may be an underestimate because 
the chicks may have been typed before the B-G and B-F antigens reached 
mature levels. Also, whether each test reagent was capable of detecting 
both the B-G and B-F antigens is unknown. Because all recombinants were 
1 19 
obtained from B B heterozygotes, this particular heterozygote combina­
tion may have been unique in permitting the detection of both the B'-G and 
B-F antigens. In the mouse, certain heterozygous combinations are known 
to have higher recombination frequencies than others. The average per­
centage recombination rate between K and D is given as 0.329 but certain 
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heterozygous combinations have yielded recombination frequencies near 
zero (Klein, 1975). That the recombination frequency within the chicken 
B complex may not be far different from that in the mouse H-2 complex is 
not surprising-
Future Studies 
Future studies of recombinant haploytypes might focus on one or more 
of several different areas. The antigen coded by the Ir-GAT locus of the 
19rl B haplotype might be immunoprecipitated with the appropriate antisera 
to determine whether it codes for the Ir-GAT-Lo or Ir-GAT-Hi gene product. 
Such an experiment should confirm the results of the immune response 
studies- Failure of Ir-GAT-Hi lymphocytes to produce one-way mixed lymph­
ocyte reactions with Ir-GAT-Lo target cells would suggest that Ir-GAT-Lo 
responders might have resulted from failure to express a structural gene. 
As suggested earlier, specifically blocking ^  vitro responses to GAT by 
binding specific monoclonal antibody to the B-L antigens on antigen-
presenting cells would provide evidence for the identity of the Ir-GAT 
locus and a B-L locus. 
Another area of interest in chickens would be the possible 
determination of the genetic mechanism of the restriction phenomena already 
extensively studied in mice. Wainberg et al. (1974) have shown that 
chicken spleen cells preferentially kill self neoplastic target cells 
rather than allogeneic target cells. If the B complex restricts killing 
by cytotoxic T cells, then certain recombinants might be useful in deter­
mining the degree to which the B-G and B-F loci influence restriction. 
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Perhaps such studies would aid in elucidating the fimctional properties 
of the B-G locus. In mice, it seems that the primary purpose of the cell 
surface alloantigens is to provide a context for antigen recognition 
(Benacerraf, 1981). Studies of restriction phenomena would help deter­
mine whether the same were true in chickens. 
Reciprocal immunizations between birds bearing different recombinant 
haplotypes produced in this study could be utilized to determine whether 
all have the same sequence of genes coding for cell surface alloantigens. 
If multiple B-G, B-F or B-L genes exist then the recombinants likely would 
have serologically detectable differences. Briles and Briles (1980) have 
already provided genetic evidence for multiple B-G loci; biochemical 
studies now lend evidence for multiple B-F and B-L loci (Brogren and 
Bisati e^ aly 1979; Crone et al., 1981). The production of additional 
recombinants for more refined analysis of the B complex should help to 
better establish the number of loci and their f-unctional properties. 
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SUMMARY 
The study consisted of the production and analysis of genetic 
recombinants of the chicken B complex, the major histocompatibility complex 
of the chicken. The purpose was to provide data complementing that of the 
1 19 
mammalian major histocompatibility complex. By mating B B heterozygotes 
2 2 to B B homozygotes, 5 recombinants were identified in 5,584 chicks tested 
by hemagglutination. The results indicate that the recombination fre­
quency within the chicken MHC is comparable to that recorded in the mouse 
where the frequency of recombination has been estimated within the range 
of near zero for certain heterozygous combinations to an average value of 
,329 of 1 percent. 
Analysis of the data indicates that the B^ parental haplotype 
19 
contributed the B-G gene and the E parental haplotype contributed the 
B-F gene to the recombinant haplotypes. The new recombinants have been 
19rl 19r2 19r3 19r4 19ir5 
designated B , B , B , B , and B . The B-F region of the 
19rl 
B haplotype controls allograft rejection, mixed lymphocyte reaction, 
and graft-versus-host splenomegaly. No functional properties could be as­
signed to the B-G genes. 
Recombination between a locus controlling immune response to the 
amino acid polymer GAT and a chromosome segment containing the B-G and 
B-F genes has previously been reported from Iowa State University studies. 
19rl 
Because the B haplotype confers high immune response to the amino acid 
47 
polymer GAT, it was likely produced from a crossover between the B-G 
locus and a chromosome segment containing the B-F and Ir-GAT-Hi genes. 
The region controlling immune response to GAT very probably is 
identical to the previously described B-L region. The putative order of 
19r2 
these regions is, therefore, B-G, B-F and B-L. The recombinants B , 
19r3 19r4 
B and B are all identical for those B complex loci which control 
histocompatibility. Additional studies with these recombinants are needed 
to determine whether they all contain the same linear sequence of genes. 
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